RxDoctor Payments Data

Billy May, MD

Family Medicine · Baton Rouge, LANPI 1215927710

Payments from drug & device makers

$4,859in general payments, 2019–2025

Across 343 payments — averaging $14.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$380
  • Takeda Pharmaceuticals U.S.A., Inc.$371
  • AstraZeneca$187
  • Amarin Pharma, Inc.$185
  • Amneal Pharmaceuticals LLC$162
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$4,79799%
  • Education$631%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,859 in reported general payments places this provider in the 80th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$185,664
Medicare patients
171
Services billed
6,627

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide59$63,736
EliquisApixaban53$40,916
OzempicSemaglutide42$40,445
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$20,830
Trijardy XrEmpaglifloz/Linaglip/Metformin29$20,495
JardianceEmpagliflozin13$14,978
FarxigaDapagliflozin Propanediol13$13,954
Liothyronine Sodium265$13,653
TrintellixVortioxetine Hydrobromide20$13,304
XareltoRivaroxaban15$12,196
Janumet XrSitagliptin Phos/Metformin Hcl14$11,281
Np ThyroidThyroid,pork224$8,955
Aimovig AutoinjectorErenumab-Aooe12$8,586
LinzessLinaclotide13$6,612
SynthroidLevothyroxine Sodium73$6,312

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$131$63,73659 claims
PfizerEliquis$111$40,91653 claims
Boehringer IngelheimTrijardy Xr, Jardiance, Stiolto Respimat$158$40,47753 claims
Novo NordiskOzempic$47$40,44542 claims
GSKTrelegy Ellipta$152$20,83029 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$371$18,65735 claims
AbbVieLinzess, Synthroid, Armour Thyroid$1,737$16,194144 claims
AstraZenecaFarxiga$187$13,95413 claims
Acella Pharmaceuticals, LLCNp Thyroid$12$8,955224 claims
Amneal Pharmaceuticals LLCUnithroid, Levothyroxine Sodium$162$3,943251 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →